American Thoracic Society
12
1
1
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
45%
5 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
Role: collaborator
HHHFA in COPD Patients, With Chronic Bronchitis
Role: collaborator
4D Medical X-ray Velocimetry for Bronchoscopic Lung Volume Reduction Targeting
Role: collaborator
Combination Drug-Therapy for Patients With Untreated Obstructive Sleep Apnea
Role: collaborator
Cognition and Obstructive Sleep Apnea in Parkinson's Disease, Effect of Positive Airway Pressure Therapy
Role: collaborator
AQI and Childhood Asthma: an Intervention
Role: collaborator
Virtual Teach to Goal vs. Brief Intervention Inhaler Study-outpatient
Role: collaborator
Study of Nicotine Patches in Patients With Sarcoidosis
Role: collaborator
The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis
Role: collaborator
Asthma Implementation Research Trial
Role: collaborator
A Study of Novel Smoking Cessation Interventions in Current and Former Injection Drug Users
Role: collaborator
A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)
Role: collaborator
All 12 trials loaded